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Abstract
Diabetes mellitus is a chronic disease caused by inherited and/or acquired
deficiency in the production of insulin by the pancreas, or by ineffectiveness of the
insulin produced. Diabetes is a life-long disease marked by elevated levels of sugar
in the blood. It is considered as the second progressing cause of color blindness and
kidney defects throughout the world. There are four times higher chances of getting
heart disease and strokes suffering with diabetes than other ailments. Type-2
diabetes has approximately 90% cases in Pakistan and need to be checked out for its
therapy. Olive oil could be helpful in diabetes via many of ways, as prolonged
inflammation plays a role as an enhancer of diabetes and other diabetes problems.
This study reports identification of some of the cheapest ways to lower the choles-
terol in the diabetes mellitus in the local population by using advanced technologies.
In this work, the main focus of the research was to use olive oil as a therapy, and as a
lipid lowering agent, to improve and reduce the chance of blood pressure, lipids,
and hence diabetes and cardiovascular diseases.
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1. In silico proteomics
Bioinformatics is a science of intellectual biology with respect to molecule
recognition as it uses informatics principles to sort out the information of molecules
on large scale. Applied math, statistics and computer laid down its foundation.
In simple words, bioinformatics work as a platform for management of data in
molecular biology field. It has many other applications too in molecular biology [1].
Bioinformatics has many applications in different fields of biology like geno-
mics, biotechnology, molecular biology, and many areas of biomedical sciences.
For instance, it is used in DNA fingerprinting, agriculture and drug designing
approaches [1]. Drug designing is done in silico by the comparative association of
ligand protein interactions; leads obtained this way provide innovative medicines.
This type of association is the base of synthetic drug designing. The 3-D structure of
proteins is studied via pyMOL or VMD softwares. These softwares clearly demon-
strate the receptor ligand relationship in drug designing process. The drug devel-
oped by this way requires less budget with greater efficiency and less or no harmful
side effects. Drug development is done utilizing informatics principles (Lagunin
et al., 2014).
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Now a days criminal are captured by using bioinformatics tools like phylogenetic
analysis provide a proof against the criminal in court of law. In forensic analysis
Bayesian statistics are utilized to detect DNA of culprit [2]. Bioinformatics has
made of healthcare system modernize with the introduction of personalized
drugs etc. [3].
Now it has become possible with the advancement in the knowledge of bioin-
formatics that genetic defects are pin pointed on time and are tried to be eliminated
before their expression. In this way better treatment has become possible in this era
(Takeichi et al., 2015). Bioinformatics has revolutionized the agriculture system
with the introduction of new and better crops varieties with increased production
potential and resistant against crop damaging agents (Katam et al., 2015).
Bioinformatics is not only limited to Allied health fields but it is also play
important role in many other fields too as given below;
• Energy sources
• Antibiotic resistance
• Biotechnology
• Bio-weapon manufacturing
• Climate change analysis
• Comparative studies
• Crop betterment
• Development of drought resistant types of plants
• Drug designing
• Evolutionary analysis
• Forensic studies
• Gene therapy
• Genome assembly
• Nutritional quality improvement
• Insect resistance
• Molecular medicine
• Personalized medicine
• Preventative medicine
• Re-sequencing
• Veterinary science
• Waste cleanup process
2
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1.1 In silico drug designing
Discovery of new drug is lengthy and expensive process and require lots of
mass efforts too. Many of the times the year’s hard work in drug discovery is wasted
away due to certain factors like toxic effects, poor drug metabolism etc. (Grinter
and Zou, 2014).
So with the advancement in the field of informatics, the drug discovery process
has been completely changed as drugs are developed in silico with the help of latest
Bioinformatics tools and applications. Today many fields use in silico drug design-
ing (Figure 1) method like biochemistry, nanotechnology and molecular biology.
This method has major advantage on others is its cost effectiveness and quickness
(Grinter and Zou, 2014).
Many outstanding tools and softwares are used for drug development by in silico
method, those includes;
• PBPK/PD modeling software
• PKUDDS
• Grid computing
• JAVA
• APIS
• Python and Perl
• MEGA
• Clustal W
Figure 1.
In silico drug designing.
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• Clustal Omega
• JALVIEW
• FATCAT server
• MN convert
• VMD
• Lipinski’s rule
• Patch dock &
• AutoDock Vina
This in silico based approach is used in every stage of drug discovery starting
from preclinical phase to terminal phase of drug development process [4].
1.2 Phytochemicals
Olea europaea (extra virgin olive oil EVOO) was selected as an anti-diabetic
agent as it has many beneficial effects like improvement of hyperglycaemia and
lowering of lipid profile of diabetic patients. That is why it was selected and its
docking was augmented against certain proteins genetically linked to diabetes.
1.3 Proteins involved in diabetes
There are following proteins which are genetically linked to diabetes, these
proteins with their characteristics and available commercial drugs against these
protein markers have been shown in Table 1.
Protein name Mol. mass
(Da)
Amino
acids
Available drugs Structure
Calcium/calmodulin-dependent
protein kinase type 1D
42,914 Da 385 No drug found Quaternary
structure
A disintegrin and metalloproteinase
with thrombospondin motifs 9
216,491 Da 1935 No drug found Quaternary
structure
Calpain-10 74,952 Da 672 No drug found Quaternary
structure
Cell division cycle protein 123
homolog
39,135 Da 336 No drug found Quaternary
structure
Threonylcarbamoyladenosine tRNA
methylthiotransferase
65,111 Da 579 No drug found Quaternary
structure
Hematopoietically expressed
homeobox protein HHEX
30,022 Da 270 No drug found Quaternary
structure
Insulin-degrading enzyme 117,968 Da 1019 6bK inhibitor Quaternary
structure
Homodimer
Insulin-like growth factor 2
mRNA-binding protein 2
66,121 Da 599 No drug found Quaternary
structure
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1.4 Significance of in silico, drug designing
In silico medical practitioner to select best suitable drug for the treatment of
disease. The drug designed by this way prove to be less toxic, fewer or no side effect
and more capable than any other drug available. In silico drug designing has appli-
cation in all the phases of new drug development process. All these in silico analysis
are done with the help of different tools and application softwares of bioinformatics
(Schmidt et al., 2014; Tian et al., 2015).
1.5 Aims of study
In silico bioinformatics analysis were used to screen and check the therapeutic
potential of Olea europaea to treat type two diabetes mellitus. For this purpose
certain proteins responsible for diabetes were selected and in silico analysis were
done to check the reversion effect of Olea europaea against these diseases causing
proteins expression. The purpose of the study was to screen and isolate potential
therapeutic agent present in the Olea europaea which could be the best treatment
option of diabetes.
1.6 Future prospective
The in silico drug development could be meaningful in the certain aspects:
Protein name Mol. mass
(Da)
Amino
acids
Available drugs Structure
Juxtaposed with another zinc finger
protein 1
27,079 Da 243 No drug found Quaternary
structure
ATP-sensitive inward rectifier
potassium channel 11
43,541 Da 390 Sulfonylurea Quaternary
structure
Potassium voltage-gated channel
subfamily KQT member 1
74,699 Da 676 Incretin Quaternary
structure
Tetramer
Leucine-rich repeat-containing
G-protein coupled receptor 5
99,998 Da 907 No drug found Quaternary
structure
Melatonin receptor type 1B 40,188 Da 362 Melatonin
supplements, DPP4
inhibitors
Quaternary
structure
Peroxisome proliferator-activated
receptor gamma
57,620 Da 505 Thiazolidinediones,
pioglitazone
Quaternary
structure
Transcription factor 7-like 2 67,919 Da 619 Sulfonylurea,
linagliptin, incretin
Quaternary
structure
Thyroid adenoma-associated
protein
219,607 Da 1953 No drug found Quaternary
structure
Tetraspanin-8 26,044 Da 237 No drug found Quaternary
structure
Wolframin 100,292 Da 890 Incretin Quaternary
structure
Table 1.
Proteins involved in diabetes along with their properties, structure and available drugs has been demonstrated.
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• Reduction of drug invention time and cost
• Harmless, effective and target specific drug development
• To improvement in result analysis
• Develop efficient bioinformatics ways and algorithms for
• Lead identification
• Lead optimization
• Target identification
• Target validation
2. Diabetes mellitus
Diabetes is a persistent ailment which happens because of the raised blood
glucose due to the lack of the body’ ability to produce insulin secretion or sufficient
insulin secretions. Insulin secretion is obtained from the pancreas gland in the body
and is prerequisite for the transport of glucose from bloodstream to the living cells
where it is utilized to obtain energy for the body. Deficit of insulin or impotence of
cells to response to insulin results in high level of blood glycaemia or
hyperglycaemia which is distinctive feature of diabetes. Hyperglycaemia, if
remained uncontrolled over long period, can cause severe damage to different body
parts leading to development of disabling or many life-threatening health issues like
cardiovascular disorders, neuropathy, nephropathy and eye diseases leading to
retinopathy and blindness. Proper management of diabetes helps prevent or delay
those complications (Atlas 2017 intro 1).
The term diabetes was initiated from Greek word “syphon” or “mellitus” means
Honeyed proposed by Rollo in late eighteenth century [5]. Matthew Dobson for the
first time reported the hyperglycemic nature of diabetes in his article during 1776;
he observed elevated glucose level in urine and plasma of patients. Holt et al. [6]
reported the raised level of ketone bodies in diabetes.
Million people die of diabetes each year, mostly from cardiovascular disease
exacerbated by lipid disorders and other complications. Identification of new treat-
ment strategies using olive oil for lipid lowering in diabetes through proteomic
analysis was needed. With the increase in the world population the proportion of
diabetes is also increasing with great speed so, the more health care budget is
needed to cope with this problem. As without proper primary strategies and care it
will take the face of epidemic which will kill millions of lives in the world. With this
speed it is possible that diabetes would become the number one killer of the world
within next coming 25 years. Abrupt actions are required to root out the diabetes
from the world.
Olive oil supplementation with daily food intake might play a protective role to
reduce lipid profile in diabetes due to the beneficial effect of olive oil exerted by its
antioxidant constituents.
In most of the cases when the disease is detected it is already too late to be cured.
The percentage of fatalities in patients is therefore very high. Not only there is a vast
number of precious lives are lost but the treatment and maintenance of such
patients is a heavy financial burden on the individual families and the national
6
Biochemical Testing - Clinical Correlation and Diagnosis
resources. It is therefore necessary that cheap and quick methods are made available
which can be used to screen population so that the diseases can be detected at a very
early stage. Research and development work based on the samples from our popu-
lation groups is essential because findings have been reported to be dependent on
race variations, and socio-economic and other factors. Thus the studies reported on
the basis of population groups in other parts of the world may not be valid at least in
some cases.
This study reports identification of some of the cheapest way to lower the
cholesterol profile in the diabetes mellitus in the local population by using
advance technologies. In this work, the prime focus was to the use of olive oil as
therapy for cholesterol lowering agent to improve and reducing the chance of
blood pressure, lipids and hence diabetes and cardiovascular disease will be
discussed. The findings from present research work would prove better
treatment options for diabetic patients by introduction and characterization of
new therapy methods.
DM is one out of many lethal melodies. It is ranked fourth deadliest malady, and
the rate of prevalence is increasing sharply. Olive oil a liquid fat captured from
olives tree crop cultivating in the Mediterranean Basin. Complete olives are pressed
to gain olive oil.
Results generated from this research will help devise for the novel diagnostic
procedures for early and control of diabetes complications in our population. These
findings will provide a base in planning better treatment strategies for diabetic
patients by suggested dose of olive oil nutritional supplement. The research work
proposed to be undertaken under this project shall elucidate the roles of olive oil in
diabetes mellitus in our population. Therapy for the diabetes to be investigated
should lead to not only saving lot of precious lives but also ensure saving of huge
numbers of man-hours and colossal amount financial resources spent on treatment
and patient maintenance. The other financial gains accruing from this project is the
application of the project results in developing therapy methods locally for routine
use in our clinical laboratories.
2.1 Classification
Diabetes has been grouped into two types since 600 BC but the clear classifica-
tion into two types was done in nineteenth century. Diabetes of young before
ketoacidosis and diabetes of obese people, later these two types were named as
MODY by WHO. By the discovery of human leukocyte antigen (HLA) and anti-
bodies in 1970, it was become clear that all the patients on insulin treatment were
suffering with autoimmune disorder [6]. WHO revised the classification into two
types of diabetes in 1980 and 1985 based on the clinical findings, which were
insulin-dependent diabetes mellitus (IDDM) and the noninsulin-dependent diabe-
tes mellitus (NIDDM). Classification of 1999 was accepted and revised with small
changes and diabetes was grouped into (T1DM), (T2DM), gestational diabetes
mellitus, and some other types [7].
For the diagnosis of diabetes, the diagnostic criterion has been adopted and
revised over and again by world health organization (WHO). The current criteria
states that diabetes is diagnosed by the elevated level of glucose in the bloodstream
of diabetic patients (Table 2).
2.2 Type 1 diabetes mellitus
T1DM is an autoimmune ailment caused when the body’s immune system attack
on the Beta-cells in the islets of pancreas gland. As a conclusion body produce very
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little or none insulin with a relative or absolute deficiency of insulin in the body.
The reason of this deadliest process are not completely understood but it is thought
that genetic susceptibility and environmental factors like viral infection, toxins and
some dietary factors could be the cause of the problem (Chapt1 type1 10). Type 1
diabetes occurs mostly in children and adolescents. It is managed with proper daily
injections of insulin otherwise the survival of the patient would be impossible.
Type 1 is diagnosed by raised level of glucose and with the specific symptoms
(Figure 2). Type 1 diabetes incidence rate in Karachi, the largest city of Pakistan is
1.02/100,000 in comparison to type 2 diabetes mellitus [8].
2.3 Type 2 diabetes mellitus
Type 2 diabetes is commonest type of diabetes throughout the world accounting
around 90% of all the diabetic patients. It is occurred due to insufficient production
of insulin or insulin resistance. During insulin resistance insulin become ineffective
as a result, body produce excessive insulin initially to control the elevated level of
Table 2.
Diabetes diagnostic criteria.
Figure 2.
The symptoms of type 1 diabetes.
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glucose but as the time passes productive ability of insulin producing cell is lost
ultimately a state of inadequate insulin production is developed. Usually type 2
diabetes occurs in older adults but it is increasingly seen in children, adolescent and
young adults due to physical inactivity, poor diet increasing level of obesity (13–15).
Type 2 diabetes alarming incidence in Pakistan is associated with poor diet etc. [9].
The estimated prevalence of Pakistan ranges from 7.6 to 11% in 2011 [10]. The
symptoms of T2DM are like T1DM (Figures 3 and 4).
2.4 Gestational diabetes mellitus (GDM)
GDM is a non-pathophysiological condition and one out of seven new born has
gestational diabetes according to [11]. GDM caused by glucose intolerance which
was first diagnosed in pregnancy period and may remain after pregnancy (Gavin III
et al., 1997). The development of undiagnosed asymptomatic T2DM and T1DM
during pregnancy is referred as GDM [12]. The occurrence of GDM is reported
during the last 6 months of the pregnancy while the development of diabetes in
women during first trimester is termed as T2DM [13].
2.5 Type 1.5 diabetes
Latent Autoimmune Diabetes in Adults (LADA) non-officially called as Type 1.5
diabetes. The term 1.5 indicates that disease is a type 1 diabetes mellitus but it shares
Figure 3.
The symptoms of typ. 2 diabetes.
Figure 4.
Different risk factors of typ. 2 diabetes mellitus (T2DM).
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some feature with type 2 diabetes mellitus that is the reason it is called as Type 1.5
diabetes means in between T1DM and T2DM. It is also known as Type 3 diabetes.
Type 1.5 diabetes is diagnosed during adulthood and has slow onset similar to T2DM
however, it is type 1 diabetes mellitus and will need insulin therapy in future.
Around 15–20% patients with type 2 diabetes are actually suffering with type 1
diabetes. They are treated with oral medication initially but will need insulin ther-
apy after some period of oral treatment. Type 1.5 diabetic patients do not have
standard symptoms of type 2 diabetes and have reduced risk of heart problem if
their blood sugar is kept in control (Diabetes, UK).
2.6 Other specific types of diabetes
Some other types of diabetes occur due to the genetic malfunctions, impaired
secretory activity of pancreas and over production of certain hormones. For
instance MODY situation affects certain genes which are responsible for beta-cells
development, functioning and regulation of glucose. Likewise excessive production
certain growth hormones, cortisol, epinephrine and glucagon enhance the glucose
production in liver cells and increase insulin resistance in muscle cells resulting in
the progression of diabetes mellitus [14]. Cystic fibrosis–related diabetes (CFRD)
occurred in cystic fibrosis patients due to insulin resistance and genetic dysfunction
of beta-cell linked with inflammation and infection [15].
2.7 Epidemiology
With every passing decade individual with diabetic ailment are increasing tre-
mendously, currently there are 425 million people suffering with diabetes and 352
million people have falsified glucose tolerance (IGT). IGT is also named as impaired
fasting glucose (IFG) or “Pre-Diabetes”. The individual with IFG has been at peak
Figure 5.
Worldwide distribution of diabetes. Adapted from: IDF diabetes (IDF 2017).
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risk of diabetes in near future. According to IDF, 1 in 11 people has diabetes till now
and it is projected to be 1 in 10 till 2040 (IDF 2017).
Pakistan is among the top 10 most affected diabetic countries of the world and is
projected to be at 8th position until 2045 (20–79 years of age. Other major countries
on the top of the list are China, India, United States, Brazil, Mexico, Indonesia,
Russian federation, Egypt, Germany and Pakistan respectively. According to latest
estimates Pakistan has 7.2 million population of diabetes and projected to be 16.1
million by 2045 (Atlas 2017). Previous studies reported 5.2 million diabetic popula-
tion of Pakistan in 2000 and projected to be 13.9 million till 2030 [16]. The world-
wide prevalence of diabetes is shown in Figure 5. In urban areas the ratio of
diabetes is 22.04% and in rural areas it is 17.15%. In Punjab, diabetes in female is
19.3% and in male it is 16.6%. In KPK it is 11.1% in both male and female in
Balochistan it is 10.8% in both [17, 18]. But in Sindh female proportion is 11.7% and
in male is 16.2% (Hussain and Ali, 2017) Figure 6 demonstrate the distribution of
diabetes in all the provinces of Pakistan (Figure 7) [19–39].
Figure 6.
Distribution of diabetes in different provinces of Pakistan [40].
Figure 7.
List of top 10 countries having diabetes (IDF Atlas 2017).
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2.8 Prevention of diabetes
As diabetes is multifactorial gene disorder, as genetic information and environ-
mental effects both play a role in this disease. Type 1 diabetes is comparatively less
affected with environmental factors but type 2 does. So, it is difficult to stop the
onset of type 1 diabetes, but for type 2 diabetes there are many known preventive
measures. These preventive measures include maintaining normal body weight, use
of healthful diet and regular physical exercise. Changing in eating habits are known
to reduce the risk of diabetes, such as taking whole grain diet, using diet with good
fats (nut, fish) and reducing use of saturated fats (red meat). But above all, limit use
of sweet edibles is the most important and effective preventive measure as well as
in controlling the complication of diabetes. In addition, if an individual quits smoking,
the risk of onset of diabetes reduces many folds (Figure 7) [41].
3. Extra virgin olive oil (EVOO)
EVOO is one of the most important components of Mediterranean diet having
many health benefits. At first, excess of (MUFA) especially oleic acid, was thought
Figure 8.
Representing health benefits of extra virgin olive oil.
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Figure 9.
Chemical structure of EVOO.
Figure 10.
Metabolism of EVOO.
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as the major beneficial constituent of virgin olive oil. Most important health benefit
of EVOO (Figure 8) is improved cardiovascular heal, reduction of inflammation
and oxidative stress. It is used in Mediterranean diet since many decades. Studies
suggested that Mediterranean food specimen along with EVOO lowers the risk of
heart disorders as compared to controls. Other studies reported that EVOO improve
hyperglycemia and lipid level in patients with dysfunctional fasting glucose
(Roberto et al., 2016). Almost 200 ‘minor particles’ in the un-saponifiable portion of
olive oil comprise about 2% of the total weight of EVOO [42–63].
3.1 Nutritional effects of EVOO
One tablespoon of EVOO contains 14 g of total fat, 2 g of saturated fats and has
no fiber, sugar, cholesterol etc. Vitamins E, K are also present in it also has phytos-
terols, a which is structurally similar to cholesterol because it hinders cholesterol
absorption from food and lower LDL values associated with heart disease. Major
EVOO polyphenols include secoiridoids, phenols, and lignans. The chemical struc-
tural formula of EVOO is shown in Figure 9 and metabolism of EVOO is shown in
Figure 10.
3.2 Effects on cholesterol level
There is no cholesterol in the EVOO while other animal obtained fats contain
different amount of cholesterol. Recently, the European Food Safety Authority
(EFSA) has reported beneficial effect of EVOO on LDL oxidation process due to its
phenolic (Figure 10).
4. Justification
Diabetes mellitus is one of the most lethal melodies of the world and ranked
fourth in deadliest diseases. It is metabolic defect that results in hyperglycaemia.
The distribution of diabetes is spreading with great speed. The diabetic mass of
Pakistan is among the top 10 diabetic populations of the world and is projected to be
at 8th position among most prevailing diabetic countries by 2045 (IDF 2017). With
this rate 1 out of 4 persons in Pakistan is diabetic. It is not a single etiological
condition but it is a multifactorial ailment that is affecting Pakistan population
severely. Diabetes has no cure at the moment only preventive and supportive
therapy is given to improve the living of people by means of oral medication and
insulin injections [63–72].
Million people die of diabetes each year, mostly from cardiovascular disease
exacerbated by lipid disorders and other complications.
Olive oil use has may a protective role to reduce the lipid profile in diabetes due
to the beneficial effect of its antioxidant level. Since oral medications and insulin are
the best possible treatment option but still these have some side effects like drugs
toxicity, renal failure and inflammation and infection at the point of injection of
insulin to minimize the effect and to obtain a better alternative treatment option
which should be natural, harmless, cheap and could prove a permanent cure of
diabetes we chose EVOO as a therapy of the type 2 diabetes.
Since there are some recent studies available which support the use of EVOO
as a lipid and glucose lowering agent in type 2 diabetes mellitus. EVOO improves
the post prandial glycaemia by incretin like mechanism in which up-regulation
of incretin took place in this way lipid and glucose levels are reduce by EVOO.
EVOO also reduce oxidative stress, inflammation lower lipid level which is the
14
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hallmark of the diabetes that is why EVOO is compound of choice for the therapy
of diabetes. The phenols in the EVOO are the major components responsible for
these beneficial effects. Due of the fact that the EVOO therapy for the treatment of
diabetes has never been studied before in the diabetic population of Pakistan we
step forward and to use this natural compound as a therapy for treatment of type 2
diabetes [72–80].
There is no study available in Pakistan that support the therapeutic effect of
EVOO in type 2 diabetes so got the idea to prove the therapeutic value of EVOO in
the Diabetic population of Pakistan, for this we selected the Lahore region that is
one of the populated city of Pakistan.
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